Concepedia

Hank Mansbach

HM

Statistics

Publications

14

Citations

1.3K

H-Index

14

Active since

2004

Affiliations

Velocity Clinical Research (United States)(Current)

University of California San Diego

Cliniques Universitaires Saint-Luc

Pinnacle Clinical Research

Institute of Cancer Research

Hank Mansbach is an author at Velocity Clinical Research (United States) specializing in pharmacology, medicine, and clinical pharmacology.

Publications per year

2004–2023

14

Publications

14

Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH

Rohit Loomba, Arun J. Sanyal, Kris V. Kowdley et al. · New England Journal of Medicine · 2023 · 442 citations · Full text

, , +9

Prevalence and Diagnosis of Migraine in Patients Consulting Their Physician With a Complaint of Headache: Data From the Landmark Study

Stewart J. Tepper, Carl Dahlöf, Andrew Dowson et al. · Headache The Journal of Head and Face Pain · 2004 · 235 citations

, , +16

The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial

Deepak L. Bhatt, Harold Bays, Michael Miller et al. · Nature Medicine · 2023 · 101 citations · Full text

, , +9

Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b/2a multiple-ascending-dose study

Rohit Loomba, Eric Lawitz, Juan P. Frías et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 99 citations

, , +8

The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Christopher P. Evans, Celestia S. Higano, Thomas E. Keane et al. · European Urology · 2016 · 90 citations

, , +11

1–5 of 14